Xavier Darzacq
Kerry Ann Kelly
Xavier Darzacq
Founder, Director
UC Berkeley professor and Eikon Therapeutics founder. Dr. Darzacq has experience in leading fundamental research on protein interactions regulating cellular processes as well as pharma technology development, guiding Eikon’s single molecule screening strategy as its CTO.
Robert Tjian
Kerry Ann Kelly
Xavier Darzacq
Founder
UC Berkeley Professor, former President of HHMI, and co-founder of Tularik, Nurix, Eikon and Lyterian with 40+ years of molecular biology and biochemistry research in gene regulation and stem cell differentiation. Dr. Tjian is also a Science Partner at The Column Group (2007-2009 & 2016-present).
Kerry Ann Kelly
Kerry Ann Kelly
Kerry Ann Kelly
Founder, Director, Head of Operations
20+ years of leadership experience in biotech and academia. Ms. Kelly has led legal and operational teams in a variety of life science organizations, including, Eikon Therapeutics, Cleave Therapeutics, Ambit Biosciences, the Scripps Research Institute,and Sugen Inc.
Jack Ferrie
Kerry Ann Kelly
Kerry Ann Kelly
Founder
Biotech entrepreneur with a broad scientific background encompassing cell biology, chemistry, and artificial intelligence/machine learning (AI/ML). Dr. Ferrie is a founder and the CEO of Sentauri, Inc., a company that provides AI/ML solutions to accelerate research across biotech and pharma.